Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Research
Research Collection: Alzheimer’s Disease
We’re delighted to launch the second Faculty Opinions Essential Reading collection: Alzheimer’s. Millions of people worldwide live with dementia, including Alzheimer’s. Our Faculty finds and assesses the literature to highlight the… Continue reading →

Read the article
KOL Engagement
Tis the Season…for Conference Planning
As we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare… Continue reading →

Read the article
no
Research
Research Collection: Opioid Addiction
We’re delighted to launch the fourth Faculty Opinions Essential Reading collection: Opioid Addiction. “Opioid abuse and addiction are major global health issues today. This collection aims to collate notable research… Continue reading →

Read the article
no
Diversity & Inclusion Drug Development
Three Essential Data Insights for Optimal Trial Site Feasibility, Inclusivity and Selection
When you google the term “clinical trial,” the first thing that comes up is the National Library of Medicine site all about clinical research. It’s a great foray and… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
New Look, Same Commitment!
I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects… Continue reading →

Read the article
no
Artificial Intelligence KOL Engagement
AI and the MSL Evolution: What Time Has Taught Us
I recently had the chance to deliver the keynote address at the 2022 MSL Society Conference in Las Vegas. It’s been a transformative year for pharma and life sciences, specifically… Continue reading →

Read the article

«‹5 6 789 10 11 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕